Adverum Biotechnologies Inc

NASDAQ:ADVM

2.54

-0.18 (-6.62%)

5:02:36 PM EDT: $2.59 +0.05 (+1.97%)

Adverum Biotechnologies Inc Stock, NASDAQ:ADVM

100 Cardinal Way, Suite A, Redwood City, California 94063

United States of America

Phone: +1.650.656.9323

Number of Employees: 121

http://www.adverum.com

Description

Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.